Inventors:
Rudolf Schohe - Wuppertal, DE
Thomas Glaser - Roesrath, DE
Jorg Traber - Lohmar, DE
George S. Allen - Nashville TN
Assignee:
Bayer Aktiengesellschaft - Leverkusen
International Classification:
A61K 31445, C07D21158
Abstract:
For treatment of disorders of the central nervous system, the cardiovascular system or the intestinal tract, the new substituted basic 2-aminotetralins of the formula ##STR1## in which R. sup. 1 represents hydrogen or alkyl,
R. sup. 2 represents hydrogen, alkyl or acyl, and
R. sup. 3 represents quinuclidine or
a group of the formula --(CH. sub. 2). sub. a --R. sup. 4, --CH. sub. 2 --CH. dbd. CH--(CH. sub. 2). sub. b --R. sup. 4, --CH. sub. 2 --C. tbd. C--(CH. sub. 2). sub. b --R. sup. 4, ##STR2## wherein a denotes a number from 1 to 10,
b denotes a number 0, 1, 2, 3 or 4,
c denotes a number 0, 1 or 2,
d denotes a number 2 or 3, and
X denotes oxygen, sulphur or NR. sup. 5,
and their salts.